ArticleDigital health
Explainable AI-driven hybrid deep learning framework for accurate skin cancer diagnosis.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To develop and evaluate a hybrid, partially interpretable deep learning (DL) approach for multi-class skin cancer classification that improves robustness under varying acquisition conditions and delivers clinically meaningful explanations. Methods: The proposed pipeline starts with preprocessing, including hair artefact removal using the Dull Razor method and anisotropic diffusion filtering for noise reduction while preserving lesion boundaries. Data augmentation is limited to the training set to prevent leakage. Class imbalance is addressed using class-weighted cross-entropy loss. EfficientNetB0 serves as the backbone CNN, and global feature embeddings are used to train a Random Forest (RF) classifier. Predictions are made by combining outputs from the deep model and the RF through probability-level fusion. The framework is evaluated on the HAM10000 dataset (7 classes) and a combined ISIC2019+DermNet dataset (8 classes). Performance metrics are compared against strong Vision Transformer (ViT) and transfer learning baselines. A proof-of-concept web application is developed for explainable decision making. Results: The proposed model achieves 98.61% accuracy and 98.60% F1-score on the combined dataset. It reaches 95.02% accuracy and 95.06% F1-score on HAM10000 using lesion-wise 5-fold cross-validation. For melanoma-specific evaluations, it demonstrates high sensitivity and AUC, indicating strong performance on critical cases. Grad-CAM maps suggest that the network highlights potentially important diagnostic lesion areas. Conclusion: The results indicate that partially interpretable architectures are a promising direction for robust skin cancer classification. The integration of Grad-CAM explanations and a web-based interface indicates that our framework may serve as a useful exploratory clinical decision-support tool.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.